Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholinesterase Inhibitor Discontinuation
NCT02248636Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2015
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Dementia (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Successful Completion of 6-week Discontinuation. Started Jan 2015; status: completed.
02
Conditions
Dementia
Beyond the preview
Go deeper on NCT02248636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248636.